Piper Jaffray raises its price target on Alnylam Pharmaceuticals Inc. (nASDAQ: ALNY) from $13 to $17 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE